Growth Metrics

Neogenomics (NEO) Current Leases (2016 - 2025)

Historic Current Leases for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $4.5 million.

  • Neogenomics' Current Leases rose 2128.63% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 2128.63%. This contributed to the annual value of $3.4 million for FY2024, which is 3973.26% down from last year.
  • As of Q3 2025, Neogenomics' Current Leases stood at $4.5 million, which was up 2128.63% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Current Leases peaked at $7.4 million during Q2 2023, and registered a low of $3.1 million during Q1 2025.
  • Moreover, its 5-year median value for Current Leases was $5.6 million (2021), whereas its average is $5.4 million.
  • As far as peak fluctuations go, Neogenomics' Current Leases soared by 4864.92% in 2021, and later plummeted by 5140.06% in 2024.
  • Quarter analysis of 5 years shows Neogenomics' Current Leases stood at $6.9 million in 2021, then fell by 4.36% to $6.6 million in 2022, then decreased by 14.79% to $5.6 million in 2023, then crashed by 39.73% to $3.4 million in 2024, then skyrocketed by 33.3% to $4.5 million in 2025.
  • Its Current Leases was $4.5 million in Q3 2025, compared to $4.1 million in Q2 2025 and $3.1 million in Q1 2025.